Rethinking Clinical Trials
MARCH 19, 2025
Dr. Alexander “AJ” Blood In this Friday’s PCT Grand Rounds, Alexander J. “AJ” Blood of Harvard Medical School and Brigham and Women’s Hospital will present “Generative Artificial Intelligence in Clinical Trials: A Driver of Efficiency and Democratization of Care.” The Grand Rounds session will be held on Friday, March 21, 2025, at 1:00 pm eastern.
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 19, 2025
Do ice baths live up to the hype? (Diana Light/Unsplash) Ice baths have become increasingly popular over the past few years. Fitness enthusiasts and casual exercisers around the world are embracing this trend that was once reserved for elite athletes. Ice baths (also known as “cold water immersion“) are exactly what they sound like.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Rethinking Clinical Trials
MARCH 19, 2025
Speaker Sean Mann Senior Policy Analyst RAND Corporation Slides Keywords Development Economics; Spillover; Bias; Pragmatic Clinical Trials Key Points Individually randomized, parallel-group embedded pragmatic trials randomly assign patients to a new healthcare intervention or to a control group that receives some form of usual care.
XTalks
MARCH 19, 2025
Join us as we celebrate a major milestone the 200th episode of the Xtalks Life Science Podcast! From groundbreaking biotech innovations to exclusive interviews with life science industry innovators and leaders, we’ve covered it all. Thank you for tuning in each week! We look forward to continuing to bring the latest and greatest across the pharma, biotech and medical industries!
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Drug Patent Watch
MARCH 19, 2025
Unlocking Strategic Investment Opportunities in the Pharmaceutical Industry As we navigate the ever-evolving landscape of the pharmaceutical industry, one thing remains constant: the expiration of patents on blockbuster medications. These expirations can have a significant impact on the market, creating opportunities for strategic investment and growth.
CTTI (Clinical Trials Transformation Initiative)
MARCH 19, 2025
A new publication from the FDA Oncology Center of Excellence (OCE) and the Clinical Trials Transformation Initiative (CTTI), published in the Clinical Cancer Research journal, provides important insights into how decentralized clinical trial (DCT) elements were used in cancer trials leading to FDA approval during the COVID-19 pandemic. DCT elementssuch as remote monitoring, telemedicine, and home delivery of investigational products were widely used in cancer trials to maintain patient safety an
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 19, 2025
The Indian Council of Medical Research (ICMR) is working to set up a Centre for Advanced Research in Aging, marking a significant move in India’s efforts to address the challenges of aging and age-related diseases.
Bio Pharma Dive
MARCH 19, 2025
The company continues to focus on a next-generation drug while batoclimab’s testing in thyroid eye disease wraps up.
Pharmaceutical Technology
MARCH 19, 2025
While the allogeneic vs autologous debate continues in the cell therapy field, research on in vivo therapies is drawing interest.
Bio Pharma Dive
MARCH 19, 2025
CEO Gina Chapman is also departing the company, which plans to review options for pursuing a reverse merger or other business combination.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
MARCH 19, 2025
The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals Cirara, aimed at treating LHI.
XTalks
MARCH 19, 2025
Eneboparatide (AZP-3601), an investigational parathyroid hormone 1 receptor (PTH1R) agonist, met its primary endpoint in the CALYPSO Phase III trial, offering new data for adults with chronic hypoparathyroidism. While detailed outcome data were not shared, suggested that the therapy significantly improved albumin-adjusted serum calcium levels and reduced reliance on active vitamin D and oral calcium therapies.
Pharmaceutical Technology
MARCH 19, 2025
Arbor Biotechnologies has closed $73.9m for its gene editing therapeutic pipeline aimed at liver and central nervous system diseases.
Bio Pharma Dive
MARCH 19, 2025
The PBM plans to stop requiring coverage reauthorization for about 80 drugs, including Vertex’s cystic fibrosis medicines and many MS treatments.
Pharmaceutical Technology
MARCH 19, 2025
Insight Health Data Research Hub and insitro have announced a partnership to develop an AI foundation model for ocular biomarkers.
Pharma Times
MARCH 19, 2025
The company is preparing to submit the results to the FDA this year
Drug Patent Watch
MARCH 19, 2025
Navigating the Complex World of Drug Patents: A Comprehensive Strategy is Key As a pharmaceutical professional, you know that developing new medications is a costly and time-consuming process. But what happens when your product's patent is about to expire, or you're facing competition from generic manufacturers? A well-crafted drug patent strategy can make all the difference in protecting your intellectual property and maintaining market share.
pharmaphorum
MARCH 19, 2025
Explore how Tufts Center for the Study of Drug Development (CSDD) has spearheaded the growth of digital clinical trials through an initial leap of faith. Learn more about todays fast-growing movement in the field.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Commerce
MARCH 19, 2025
The conferences first panel offers insight on the current state of awareness among beneficiaries of the Part D cap and Medicare Prescription Payment Plan via the PAN Foundations latest research.
pharmaphorum
MARCH 19, 2025
Google has said it will release new open-source AI models for drug discovery, TxGemma, through a developers' programme later this month
Pharmaceutical Commerce
MARCH 19, 2025
Jonathan James, CEO, Hope Charities, discusses reimbursement challenges and barriers to care in patients requiring life-saving medications.
pharmaphorum
MARCH 19, 2025
Novartis will cut 427 jobs this year in the US as it prepares for the loss of market exclusivity for its blockbuster heart failure therapy Entresto
Pharmaceutical Commerce
MARCH 19, 2025
A roundtable explores how patient access needs are being measured, while also discussing the value of affordability in decision-making.
pharmaphorum
MARCH 19, 2025
Oxford BioTherapeutics has lined up another big pharma partner for its drug discovery platform, signing a $1bn deal with oncology giant Roche
Pharmaceutical Commerce
MARCH 19, 2025
Jonathan James, CEO, Hope Charities, discusses reimbursement challenges and barriers to care in patients requiring life-saving medications.
pharmaphorum
MARCH 19, 2025
2nd GLP-1-Based Therapeutics Summit Sara.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Commerce
MARCH 19, 2025
The latest news for pharma industry insiders.
pharmaphorum
MARCH 19, 2025
Discover how Japan is leading the way in oncology clinical trials through the implementation of Decentralised Clinical Trials (DCT). Learn about the innovative approaches and advancements shaping the future of cancer research.
XTalks
MARCH 19, 2025
A 16-year-old patient died after treatment with Elevidys (delandistrogene moxeparvovec), Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy (DMD). The patient suffered acute liver failure several months after receiving the therapy in December. Liver injury is a known risk with Elevidys and other gene therapies that use adeno-associated viral (AAV) vectors.
pharmaphorum
MARCH 19, 2025
In February 2025, Changing Faces highlights notable hires at prominent agencies, consultancies, and investor firms such as Inizio Advisory, Pfizer, Omnicom, Finn Partners and more. Stay updated with the latest industry moves and appointments.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
200 
Let's personalize your content